ELDN logo

Eledon Pharmaceuticals (ELDN) Retained Earnings

Annual Retained Earnings

-$243.19 M
-$40.33 M-19.88%

December 31, 2023


Summary


Performance

ELDN Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELDNbalance sheetmetrics:

Quarterly Retained Earnings

-$310.97 M
+$76.97 M+19.84%

September 30, 2024


Summary


Performance

ELDN Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELDNbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ELDN Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.9%-33.1%
3 y3 years-202.5%-33.1%
5 y5 years-485.0%-33.1%

ELDN Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-111.7%at low-170.7%+19.8%
5 y5-year-322.3%at low-440.1%+19.8%
alltimeall time-1590.0%at low-2061.0%+19.8%

Eledon Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$310.97 M(-19.8%)
Jun 2024
-
-$387.94 M(+53.0%)
Mar 2024
-
-$253.49 M(-20.6%)
Dec 2023
-$243.19 M(+19.9%)
-$319.40 M(+36.8%)
Sep 2023
-
-$233.56 M(+4.6%)
Jun 2023
-
-$223.22 M(+4.5%)
Mar 2023
-
-$213.64 M(+5.3%)
Dec 2022
-$202.87 M(+76.6%)
-$202.87 M(+40.4%)
Sep 2022
-
-$144.48 M(+7.8%)
Jun 2022
-
-$134.01 M(+7.4%)
Mar 2022
-
-$124.76 M(+8.6%)
Dec 2021
-$114.90 M(+42.9%)
-$114.90 M(+8.3%)
Sep 2021
-
-$106.09 M(+10.2%)
Jun 2021
-
-$96.28 M(+8.3%)
Mar 2021
-
-$88.89 M(+10.6%)
Dec 2020
-$80.39 M(+39.6%)
-$80.39 M(+7.9%)
Sep 2020
-
-$74.49 M(+9.0%)
Jun 2020
-
-$68.34 M(+3.9%)
Mar 2020
-
-$65.76 M(+14.2%)
Dec 2019
-$57.58 M
-$57.58 M(+7.8%)
Sep 2019
-
-$53.44 M(+5.7%)
Jun 2019
-
-$50.55 M(+8.8%)
DateAnnualQuarterly
Mar 2019
-
-$46.45 M(+11.7%)
Dec 2018
-$41.57 M(+51.1%)
-$41.57 M(+12.4%)
Sep 2018
-
-$37.00 M(+10.4%)
Jun 2018
-
-$33.50 M(+10.5%)
Mar 2018
-
-$30.31 M(+10.2%)
Dec 2017
-$27.51 M(+91.1%)
-$27.51 M(+8.3%)
Sep 2017
-
-$25.40 M(+13.2%)
Jun 2017
-
-$22.43 M(-87.1%)
Mar 2017
-
-$173.26 M(+1104.1%)
Dec 2016
-$14.39 M(-89.1%)
-$14.39 M(-91.3%)
Sep 2016
-
-$165.66 M(+5.9%)
Jun 2016
-
-$156.39 M(+9.5%)
Mar 2016
-
-$142.86 M(+8.7%)
Dec 2015
-$131.44 M(+52.2%)
-$131.44 M(+9.1%)
Sep 2015
-
-$120.42 M(+10.9%)
Jun 2015
-
-$108.57 M(+9.0%)
Mar 2015
-
-$99.61 M(+15.4%)
Dec 2014
-$86.35 M(+36.9%)
-$86.35 M(+7.7%)
Sep 2014
-
-$80.14 M(+8.7%)
Jun 2014
-
-$73.75 M(+17.0%)
Dec 2013
-$63.05 M(+33.2%)
-$63.05 M
Dec 2012
-$47.33 M
-

FAQ

  • What is Eledon Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Eledon Pharmaceuticals?
  • What is Eledon Pharmaceuticals annual retained earnings year-on-year change?
  • What is Eledon Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Eledon Pharmaceuticals?
  • What is Eledon Pharmaceuticals quarterly retained earnings year-on-year change?

What is Eledon Pharmaceuticals annual retained earnings?

The current annual retained earnings of ELDN is -$243.19 M

What is the all time high annual retained earnings for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high annual retained earnings is -$14.39 M

What is Eledon Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, ELDN annual retained earnings has changed by -$40.33 M (-19.88%)

What is Eledon Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of ELDN is -$310.97 M

What is the all time high quarterly retained earnings for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high quarterly retained earnings is -$14.39 M

What is Eledon Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, ELDN quarterly retained earnings has changed by -$77.40 M (-33.14%)